Integrum

The new program focuses on significantly reducing service turnaround times and delivering a streamlined, efficient customer experience for Axor™ II devices in the U.S. With this initiative, Integrum aims to provide unmatched support to clinicians and amputees, ensuring continuity of care and optimal device performance.

“This initiative is a key milestone in strengthening our U.S. presence, improving customer satisfaction, and helping providers maximize the value of our solutions,” said Scott Flora, CEO of Integrum.

As Integrum accelerates its U.S. market expansion, the company remains dedicated to empowering amputees and supporting clinicians who deliver life-changing care.